Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision note is added: Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. This appears to be a minor site maintenance update with no changes to study content or user interactions.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page shows a minor system revision update from v3.4.0 to v3.4.1; there are no changes to core content, trial details, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedNew revision label 'Revision: v3.3.4' appears, replacing the previous 'Revision: v3.3.3'. This is a minor update that does not affect the study details or outcomes.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now includes a dedicated Locations section with the Texas site information and updates the page revision to v3.3.3. The old 'Texas Locations' label and the previous revision v3.3.2 have been removed.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.